BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23438850)

  • 1. Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA.
    Chmelařová M; Křepinská E; Spaček J; Laco J; Nekvindová J; Palička V
    Folia Biol (Praha); 2012; 58(6):246-50. PubMed ID: 23438850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation analysis of tumor suppressor genes in endometroid carcinoma of endometrium using MS-MLPA.
    Dvorakova E; Chmelarova M; Laco J; Palicka V; Spacek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):298-303. PubMed ID: 23736679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of Tumour Suppressor Gene Methylation in Sinonasal Carcinomas.
    Chmelařová M; Sirák I; Mžik M; Sieglová K; Vošmiková H; Dundr P; Němejcová K; Michálek J; Vošmik M; Palička V; Laco J
    Folia Biol (Praha); 2016; 62(3):110-9. PubMed ID: 27516190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
    Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
    Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of GATA4, WIF1, NTRK1 and other selected tumour suppressor genes in ovarian cancer.
    Chmelařová M; Dvořáková E; Špaček J; Laco J; Mžik M; Palička V
    Folia Biol (Praha); 2013; 59(2):87-92. PubMed ID: 23746174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of MGMT, CDH1, RAR-beta and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin.
    Dhillon VS; Young AR; Husain SA; Aslam M
    Br J Cancer; 2004 Feb; 90(4):874-81. PubMed ID: 14970867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer.
    Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
    Indian J Med Res; 2014 Nov; 140(5):616-23. PubMed ID: 25579142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated DNA methylation in malignant tumors of the sinonasal tract and its association with patient survival.
    Chmelarova M; Laco J; Kovarikova H; Baranova I; Dundr P; Nemejcova K; Michalek J; Vosmik M; Palicka V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):232-238. PubMed ID: 29581595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.
    Livide G; Epistolato MC; Amenduni M; Disciglio V; Marozza A; Mencarelli MA; Toti P; Lazzi S; Hadjistilianou T; De Francesco S; D'Ambrosio A; Renieri A; Ariani F
    Pathol Oncol Res; 2012 Jul; 18(3):703-12. PubMed ID: 22278416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation in the p53 promoter in epithelial ovarian cancer.
    Chmelarova M; Krepinska E; Spacek J; Laco J; Beranek M; Palicka V
    Clin Transl Oncol; 2013 Feb; 15(2):160-3. PubMed ID: 22855178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
    Kornegoor R; Moelans CB; Verschuur-Maes AH; Hogenes MCh; de Bruin PC; Oudejans JJ; van Diest PJ
    Breast Cancer Res; 2012 Jul; 14(4):R101. PubMed ID: 22765268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma.
    Mžik M; Chmelařová M; John S; Laco J; Slabý O; Kiss I; Bohovicová L; Palička V; Nekvindová J
    Clin Chem Lab Med; 2016 Dec; 54(12):1971-1980. PubMed ID: 27171388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-specific multiplex ligation-dependent probe amplification identifies promoter methylation events associated with survival in glioblastoma.
    Rankeillor KL; Cairns DA; Loughrey C; Short SC; Chumas P; Ismail A; Chakrabarty A; Lawler SE; Roberts P
    J Neurooncol; 2014 Apr; 117(2):243-51. PubMed ID: 24554053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
    Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
    Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.
    Ooft ML; van Ipenburg J; van Loo R; de Jong R; Moelans C; Braunius W; de Bree R; van Diest P; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
    J Clin Pathol; 2018 Apr; 71(4):351-359. PubMed ID: 28893862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA).
    Moelans CB; Atanesyan L; Savola SP; van Diest PJ
    Methods Mol Biol; 2018; 1708():537-549. PubMed ID: 29224162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).
    Ruscito I; Dimitrova D; Vasconcelos I; Gellhaus K; Schwachula T; Bellati F; Zeillinger R; Benedetti-Panici P; Vergote I; Mahner S; Cacsire-Tong D; Concin N; Darb-Esfahani S; Lambrechts S; Sehouli J; Olek S; Braicu EI
    Eur J Cancer; 2014 Aug; 50(12):2090-8. PubMed ID: 24889916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
    Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
    Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.